| Ji Young Kim, | |
|
200 West Hospital Drive, Whiteriver, AZ 85941 | |
| (928) 338-4911 | |
| Not Available |
| Full Name | Ji Young Kim |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 200 West Hospital Drive, Whiteriver, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104364413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH60593942 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ji Young Kim, Po Box 1294, Whiteriver, AZ 85941-1294 Ph: () - | Ji Young Kim, 200 West Hospital Drive, Whiteriver, AZ 85941 Ph: (928) 338-4911 |
News Archive
Obese people report sexual problems such as lack of desire, lack of enjoyment, avoiding sex and performance difficulty at a much higher rate than people of normal weight – in some cases, they are 25 times more likely to report problems, according to the Duke study.
Irinotecan plus cisplatin remains the gold standard for Japanese patients with extensive small-cell lung cancer, say researchers, after amrubicin plus cisplatin failed to improve survival in their randomised phase III trial.
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has completed its previously announced acquisition of the Interactive Voice and Web Response Services (IVRS/IWRS) business of Covance Inc. (NYSE: CVD). Phase Forward purchased the Covance business unit for $10 million in cash. As part of the transaction, Phase Forward and Covance have entered into a multi-year marketing agreement to provide Phase Forward's market-leading InForm™ electronic data capture (EDC) solution and Clarix™ Interactive Response Technology (IRT) application as the preferred EDC and IRT solutions to Covance clients.
The composition of inflammatory lung infiltrate in people with pneumonia caused by Streptococcus pneumoniae differs by age, an in-situ study reveals.
In the last several years, targeted therapies - drugs that directly impact specific genes and proteins involved in the progression of cancer - have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer. Now, researchers at The Wistar Institute have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, and understanding this phenomenon may lead to a new melanoma target or prompt new designs of these treatments.
› Verified 1 days ago
Zebedee Walpert, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 West Hospital Drive, Whiteriver, AZ 85941 Phone: 928-338-4911 | |
Dr. Matthew Thomas Washburn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Hospital Dr, Whiteriver Indian Hospital, Whiteriver, AZ 85941 Phone: 928-338-3501 Fax: 928-338-3510 | |
Dr. Jared Lee Hochstettler, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Hospital Dr., Whiteriver, AZ 85941 Phone: 928-338-4911 | |
Lia M Jasperse, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 West Hospital Drive, Whiteriver, AZ 85941 Phone: 928-338-3502 Fax: 928-338-3510 | |
Dr. Endrit Toska, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Hospital Dr, Whiteriver, AZ 85941 Phone: 928-338-3502 | |
Larissa Worster, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Hospital Dr, Whiteriver, AZ 85941 Phone: 928-338-4911 | |
Daniel J Mccarville, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Hospital Dr, Whiteriver, AZ 85941 Phone: 928-338-5500 |